Analysis of fibroblast growth factor receptor 3 S249C mutation in cervical carcinoma

被引：7
|
作者：
Yee, CJ
Lin, O
Boyd, J
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol & Breast Res Lab, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Human Genet, Gynecol & Breast Res Lab, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 22期
关键词：
D O I：
10.1093/jnci/92.22.1848
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1848 / 1849
页数：2
相关论文
共 50 条
  • [31] FIBROBLAST GROWTH FACTOR RECEPTOR2 IIIC IN CERVICAL CANCER
    Kawase, R.
    Ishiwata, T.
    Takeshita, T.
    Naito, Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 692 - 692
  • [32] Targeting Fibroblast Growth Factor Receptor Signaling in Hepatocellular Carcinoma
    Cheng, Ann-Lii
    Shen, Ying-Chun
    Zhu, Andrew X.
    ONCOLOGY, 2011, 81 (5-6) : 372 - 380
  • [33] A Congenital Anterior Staphyloma with Genetically Confirmed Achondroplasia with the Fibroblast Growth Factor Receptor 3 Mutation
    Warning, Jasmin Sophie
    Hosel, Kristin
    Saeger, Mark
    Nolle, Bernhard
    Oschlies, Ilske
    Roider, Johann
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (12) : 1454 - 1456
  • [34] Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia
    Tonoki, H
    Nakae, J
    Tajima, T
    Shinohara, N
    Monji, J
    Satoh, S
    Fujieda, K
    JAPANESE JOURNAL OF HUMAN GENETICS, 1995, 40 (04): : 347 - 349
  • [35] Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma
    Wakulich, C
    Jackson-Boeters, L
    Daley, TD
    Wysocki, GP
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2002, 93 (05): : 573 - 579
  • [36] Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment
    Song, Yuxuan
    Peng, Yun
    Qin, Caipeng
    Wang, Yulong
    Yang, Wenbo
    Du, Yiqing
    Xu, Tao
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
  • [37] EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR AND FIBROBLAST GROWTH-FACTOR RECEPTOR IN ADVANCED GASTRIC-CARCINOMA
    UEKI, T
    KOJI, T
    TAMIYA, S
    NAKANE, PK
    TSUNEYOSHI, M
    JOURNAL OF PATHOLOGY, 1995, 177 (04): : 353 - 361
  • [38] Knockdown by shRNA identifes S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
    Tomlinson, D. C.
    Hurst, C. D.
    Knowles, M. A.
    ONCOGENE, 2007, 26 (40) : 5889 - 5899
  • [39] Vofatamab Fibroblast growth factor receptor 3 (FGFR-3) antibody Treatment of urothelial carcinoma
    Hanna, K. S.
    DRUGS OF THE FUTURE, 2020, 45 (06) : 383 - 388
  • [40] Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer
    D C Tomlinson
    C D Hurst
    M A Knowles
    Oncogene, 2007, 26 : 5889 - 5899
12345